Gut Dysbiosis Linked to Mortality for Solid Organ Transplant Recipients
By Elana Gotkine HealthDay Reporter
THURSDAY, July 18, 2024 -- For solid organ transplant recipients, gut dysbiosis is associated with all-cause and cause-specific mortality, according to a study published online July 2 in Gut.
J. Casper Swarte, from the University Medical Centre in Groningen, Netherlands, and colleagues analyzed 1,337 metagenomes derived from fecal samples of 766 kidney, 334 liver, 170 lung, and 67 heart transplant recipients from the TransplantLines Biobank and Cohort. An additional 8,208 metagenomes from the general population of the same geographical area were included to analyze gut dysbiosis. The association between multiple indicators of gut dysbiosis, including individual species abundances, and all-cause and cause-specific mortality was examined using multivariable Cox regression and a machine learning algorithm.
The researchers identified two patterns representing microbiome community variation that were associated with all-cause and cause-specific mortality. There was an association between the gut microbiome distance between each transplantation recipient to the average of the general population with all-cause mortality and death from infection, malignancy, and cardiovascular disease. Twenty-three bacterial species that were associated with all-cause mortality were identified; a balance consisting of 19 of 23 species that were associated with all-cause mortality was identified by applying a machine learning algorithm.
"Our results support emerging evidence showing that gut dysbiosis is associated with long-term survival, indicating that gut-microbiome targeting therapies might improve patient outcomes although causal links should be identified first," the authors write.
The TransplantLines Biobank and Cohort study received funding from Astellas BV and Chiesi Pharmaceuticals BV.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis
TUESDAY, June 10, 2025 -- Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of cardiovascular...
Early, Preemptive Kidney Transplant No Aid to Mortality
FRIDAY, June 6, 2025 -- There is no mortality benefit to receive an early, preemptive kidney transplant, according to a study published in the May issue of Transplantation...
Post-Kidney Transplant Adverse Outcomes Increased With BMI-BSA Obesity
TUESDAY, May 27, 2025 -- Combined body mass index (BMI)-body surface area (BSA) obesity is associated with an increased risk for post-kidney transplant (KT) adverse outcomes...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.